DIR provides significantly better consistency in transfer of OAR from CTprev to CTcurrent and reduces variability in EQD2-dose evaluations compared to RIR. This supports preferential use of DIR for reirradiation planning in lung cancer.
Sand et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: